Trends in the treatment of cutaneous T-cell lymphoma – critical evaluation and perspectives on vorinostat
Sophia Rangwala, Madeleine Duvic, Chunlei ZhangDepartment of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAAbstract: Epigenetic modification with small molecule histone deacetylase inhibitors has been a promising new anti-neoplastic approach for various solid and...
Guardado en:
Autores principales: | Zhang CL, Duvic M, Rangwala S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a3c1e6d15fda411cb1a406a59d3ef5d8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
por: Bodiford A, et al.
Publicado: (2015) -
Reduced intensity treatment in early-stage Hodgkin’s lymphoma
por: Armitage JO, et al.
Publicado: (2011) -
mTOR inhibitor in the treatment of Hodgkin’s lymphoma: a case report
por: Provencio M., et al.
Publicado: (2011) -
First-line therapy of chronic myeloid leukemia – focus on dasatinib
por: Amrein PC
Publicado: (2012) -
Developments in anaplastic large-cell lymphoma: targeting the anaplastic lymphoma kinase
por: Farina F, et al.
Publicado: (2014)